Recombinant Human Coagulation Factor Ⅷ (Zhuangya Biotechnology)

重组人凝血因子Ⅷ（庄亚生物）

Report date: 2023/05/11 20:00:41

Base Information

Drug NameRecombinant Human Coagulation Factor Ⅷ (Zhuangya Biotechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacements
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesZhuangya (Beijing) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuangya (Beijing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A